Services

Histology

Pharmacology

Medical Device Testing

In Vitro Screening

Animal Model Development

Custom Assay Development

Vivarium Rental

Toxicology

Species

Non-human Primates

Dogs

Mini-Pigs / Pigs

Rabbits

Mice

Rats

Sheep

Guinea Pigs

Hamsters

Other Species

Therapeutic Areas

Oncology

Immunology & Inflammation

Neurology / CNS

Cardiovascular

Dermatology & Wound Healing

Metabolism

Gastroenterology

Hepatology

Pulmonology

Infectious Diseases & Sepsis

Musculoskeletal

Nephrology & Urology

Capabilities

GLP / IND-Enabling Studies

Small and Large Animal Housing

Bioanalytical Platforms

About

News

Contact

Career

Request a Quote

Logo
☰
  • Services ⌄
    • Histology
    • Pharmacology
    • Medical Device Testing
    • In Vitro Screening
    • Animal Model Development
    • Custom Assay Development
    • Vivarium Rental
    • Toxicology
  • Species ⌄
    • Non-human Primates
    • Dogs
    • Mini-Pigs / Pigs
    • Rabbits
    • Mice
    • Rats
    • Sheep
    • Guinea Pigs
    • Hamsters
    • Other Species
  • Therapeutic Areas ⌄
    • Oncology
    • Immunology & Inflammation
    • Neurology / CNS
    • Cardiovascular
    • Dermatology & Wound Healing
    • Metabolism
    • Gastroenterology
    • Hepatology
    • Pulmonology
    • Infectious Diseases & Sepsis
    • Musculoskeletal
    • Nephrology & Urology
  • Capabilities ⌄
    • GLP / IND-Enabling Studies
    • Small and Large Animal Housing
    • Bioanalytical Platforms
  • About ⌄
    • News
  • Contact ⌄
    • Career
    • Request a Quote

Legislative Update — Week of Aug. 28, 2023

  • Post author:PacConAdmin
  • Post published:August 28, 2023
  • Post category:Uncategorized
  • Post comments:0 Comments

As the 118th Congress continues, FDAnews will track important pending legislation to keep you updated on laws and regulations that could impact your business. Source: Drug Industry Daily

Continue ReadingLegislative Update — Week of Aug. 28, 2023

Withings’ $400 Health Station Gets FDA Clearance to Measure ECG, Body Composition

  • Post author:PacConAdmin
  • Post published:August 28, 2023
  • Post category:Uncategorized
  • Post comments:0 Comments

Withings’ Body Scan health station received FDA clearance for its weight-scale style device that provides users a home electrocardiogram (ECG). Source: Drug Industry Daily

Continue ReadingWithings’ $400 Health Station Gets FDA Clearance to Measure ECG, Body Composition

Medicare Negotiation Drugs May Be Revealed Early; AstraZeneca Joins IRA Challenge

  • Post author:PacConAdmin
  • Post published:August 25, 2023
  • Post category:Uncategorized
  • Post comments:0 Comments

As word comes out that the Biden Administration may do a two-days-early reveal on the 10 drugs to be discounted through the Inflation Reduction Act (IRA), another pharma company —…

Continue ReadingMedicare Negotiation Drugs May Be Revealed Early; AstraZeneca Joins IRA Challenge

CVS Takes Aim at Private Label Biosimilars With New Subsidiary Cordavis

  • Post author:PacConAdmin
  • Post published:August 25, 2023
  • Post category:Uncategorized
  • Post comments:0 Comments

CVS Health has launched a subsidiary, Cordavis, to work directly with manufacturers to commercialize and/or co-produce FDA-approved biosimilar products at more affordable prices. Source: Drug Industry Daily

Continue ReadingCVS Takes Aim at Private Label Biosimilars With New Subsidiary Cordavis

FDA to Delay Enforcement of DSCSA Requirements Until November 2024

  • Post author:PacConAdmin
  • Post published:August 25, 2023
  • Post category:Uncategorized
  • Post comments:0 Comments

The FDA “does not intend” to enforce the Drug Supply Chain Security Act (DSCSA) requirement that manufacturers electronically capture and share data that will track a drug at the individual…

Continue ReadingFDA to Delay Enforcement of DSCSA Requirements Until November 2024

Regulatory Update — Week of Aug. 21, 2023

  • Post author:PacConAdmin
  • Post published:August 25, 2023
  • Post category:Uncategorized
  • Post comments:0 Comments

Over the past week, the FDA issued a draft guidance on product-specific guidances, extended the comment period on a draft guidance for human cellular and gene therapy products, published a…

Continue ReadingRegulatory Update — Week of Aug. 21, 2023

Quick Notes: Medical Device Development and Approvals

  • Post author:PacConAdmin
  • Post published:August 25, 2023
  • Post category:Uncategorized
  • Post comments:0 Comments

The FDA has announced a new testing tool, and approved several systems for cryoablation, donor lung preservation and cervical disc replacement. Source: Drug Industry Daily

Continue ReadingQuick Notes: Medical Device Development and Approvals

HHS Awards $1.4B for New COVID Tools, $24M for mRNA Cancer-Fighting Tech

  • Post author:PacConAdmin
  • Post published:August 24, 2023
  • Post category:Uncategorized
  • Post comments:0 Comments

HHS announced a slate of new funding initiatives this week, including $1.4 billion for Project NextGen to support development of novel COVID-19 technologies and $24 million for Curing the Uncurable…

Continue ReadingHHS Awards $1.4B for New COVID Tools, $24M for mRNA Cancer-Fighting Tech

Draeger Carina Ventilator Recalled for Potential PE-PUR Airpath Contaminants

  • Post author:PacConAdmin
  • Post published:August 24, 2023
  • Post category:Uncategorized
  • Post comments:0 Comments

Draeger Medical has voluntarily recalled its Carina Sub-Acute Care ventilators — which the FDA has deemed a class I recall — to address the potential presence of contaminants in the…

Continue ReadingDraeger Carina Ventilator Recalled for Potential PE-PUR Airpath Contaminants

Research Round-Up — August 2023

  • Post author:PacConAdmin
  • Post published:August 24, 2023
  • Post category:Uncategorized
  • Post comments:0 Comments

This month, FDAnews tackles studies for two promising obesity drugs, a first-of-its-kind pneumococcal vaccine for adults and a partial clinical hold for a blood cancer drug. Source: Drug Industry Daily

Continue ReadingResearch Round-Up — August 2023
  • Go to the previous page
  • 1
  • …
  • 130
  • 131
  • 132
  • 133
  • 134
  • 135
  • 136
  • …
  • 143
  • Go to the next page

Stay Connected

Keep up with the latest news & insights.

Contact Us

Phone:
+1 858-605-5882
Fax:
+1 858-605-5916
Email:
info@biolegacyresearch.com
Mail:

6042 Cornerstone Court W

Suite E

San Diego, CA 92121

Social:
© 2025 BioLegacy Research. All rights reserved.